Skip to main content
. 2016 Jan 5;2016:7413963. doi: 10.1155/2016/7413963

Figure 4.

Figure 4

Representative original recordings of effects of ICV infusion of sarthran (15 nmol) or A779 (500 pmol) on cardiovascular activities in sedentary or exercised SHR groups (a, d). ABP: arterial blood pressure; MAP: mean arterial pressure; bpm: beats/min. Percent changes in mean arterial pressure (b, e) and HR (c, f) induced by ICV infusion of sarthran (15 nmol) or A779 (500 pmol) in the two groups. n = 5 in each group. P < 0.05 versus SHR-Sed.